In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents
- PMID: 2221872
- PMCID: PMC171884
- DOI: 10.1128/AAC.34.8.1609
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents
Abstract
The susceptibilities of 45 clinical and 3 environmental isolates of Xanthomonas maltophilia to 14 antimicrobial agents was determined by broth microdilution. The newer quinolones PD117596, PD117558, PD127391, A-56620, amifloxacin, and fleroxacin were the most active agents tested, with 70 to 99% of isolates being susceptible to these agents. All isolates were resistant to trospectomycin. The new aminoglycosides SCH24120 and SCH22591 were active against 12 and 1% of isolates, respectively.
Similar articles
-
In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.Antimicrob Agents Chemother. 1994 Jan;38(1):134-7. doi: 10.1128/AAC.38.1.134. Antimicrob Agents Chemother. 1994. PMID: 8141567 Free PMC article.
-
Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer.Antimicrob Agents Chemother. 1990 Sep;34(9):1812-3. doi: 10.1128/AAC.34.9.1812. Antimicrob Agents Chemother. 1990. PMID: 2285297 Free PMC article.
-
Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.Antimicrob Agents Chemother. 1979 Dec;16(6):833-7. doi: 10.1128/AAC.16.6.833. Antimicrob Agents Chemother. 1979. PMID: 533264 Free PMC article.
-
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.J Antimicrob Chemother. 1991 Jun;27(6):793-9. doi: 10.1093/jac/27.6.793. J Antimicrob Chemother. 1991. PMID: 1657857
-
In vitro antimicrobial susceptibilities of Nocardia species.Antimicrob Agents Chemother. 1993 Apr;37(4):882-4. doi: 10.1128/AAC.37.4.882. Antimicrob Agents Chemother. 1993. PMID: 8494385 Free PMC article.
Cited by
-
In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.Antimicrob Agents Chemother. 1994 Jan;38(1):134-7. doi: 10.1128/AAC.38.1.134. Antimicrob Agents Chemother. 1994. PMID: 8141567 Free PMC article.
-
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.Antimicrob Agents Chemother. 1994 Mar;38(3):624-7. doi: 10.1128/AAC.38.3.624. Antimicrob Agents Chemother. 1994. PMID: 8203865 Free PMC article.
-
Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients.Infection. 2009 Apr;37(2):117-22. doi: 10.1007/s15010-008-8150-8. Epub 2008 Dec 5. Infection. 2009. PMID: 19148575
-
In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.Drugs. 1995;49 Suppl 2:246-9. doi: 10.2165/00003495-199500492-00057. Drugs. 1995. PMID: 8549319 No abstract available.
-
Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.Antimicrob Agents Chemother. 1998 Aug;42(8):2002-5. doi: 10.1128/AAC.42.8.2002. Antimicrob Agents Chemother. 1998. PMID: 9687397 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical